The Journal of Nutritional Biochemistry
Volume 15, Issue 9 , Pages 534-539 , September 2004

Biochemical responses of healthy subjects during dietary supplementation with L-arginine

  • Rhobert W. Evans

      Affiliations

    • Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 15261, USA
    • Corresponding Author InformationCorresponding author. Tel: (412) 624-2020; fax: (412) 624-3120
    • ,
  • John D. Fernstrom

      Affiliations

    • Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA 15261, USA
    • ,
  • Julie Thompson

      Affiliations

    • Ionics Instruments Business Group, Boulder, CO 80301, USA
    • ,
  • Sidney M. Morris Jr

      Affiliations

    • Department of Molecular Genetics and Biochemistry, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15261, USA
    • ,
  • Lewis H. Kuller

      Affiliations

    • Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 15261, USA

Received 15 June 2003 ,Revised 15 February 2004 ,Accepted 1 March 2004.

References 

  1. Moncada S, Palmer RMJ, Higgs EA. Biosynthesis of nitric oxide from L-arginine. Biochem Pharmacology. 1989;38:1709–1715
  2. Böger RH, Bode-Böger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 2001;42:79–99
  3. Ignarro LJ. Nitric oxide. Biology and pathobiology. San Diego: Academic Press; 2000;
  4. Visek WJ. Arginine needs, physiological state and usual diets (A reevaluation). J Nutr. 1986;116:36–46
  5. Wu G, Morris SM. Arginine metabolism (nitric oxide and beyond). Biochem. J. 1998;336:1–17
  6. Beaumier L, Castillo L, Yu Y-M, Ajami AM, Young VR. Arginine (New and exciting developments for an “old” amino acid). Biomed Environ Sci. 1996;9:296–315
  7. Wu G. Synthesis of citrulline and arginine from proline in enterocytes of postnatal pigs. Am J Physiol. 1997;272(Gastrointest Liver Physiol 35):G1382–G1390
  8. Barbul A. Arginine (Biochemistry, physiology, and therapeutic implications). J Parenter Enter Nutr. 1986;10:227–238
  9. Flynn NE, Meininger CJ, Haynes TE, Wu G. The metabolic basis of arginine nutrition and pharmacotherapy. Biomed Pharmacother. 2002;56:427–438
  10. Cyonber L. Immune-enhancing diets for stressed patients with special emphasis on arginine content (Analysis of the analysis). Curr Opin Clin Nutr Metab Care. 2003;6:189–193
  11. Griffith OW, Stuehr DJ. Nitric oxide synthases (Properties and catalytic mechanism). Annu Rev Physiol. 1995;57:707–736
  12. Forstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 1994;23:1121–1131
  13. Kurz S, Harrison DG. Insulin and the arginine paradox. J Clin Invest. 1997;99:369–370
  14. Tsikas D, Boger RH, Sandmann J, Bode-Boger SM, Frolich JC. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett. 2000;478:1–3
  15. Pettersson A, Uggla L, Backman V. Determination of dimethylated arginines in human plasma by high-performance liquid chromatography. J Chromatogr. 1997;692:257–262
  16. Heinegard D, Tiderstrom G. Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta. 1973;43:305–310
  17. Bondar RJL, Mead DC. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin Chem. 1974;20:586–590
  18. Tangphao O, Grossman M, Chalon S, Hoffman BB, Terrence F. Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. Br J Clin Pharmacol. 1999;47:261–266
  19. Reyes AA, Karl IE, Klahr S. Role of arginine in health and in renal disease. Am J Physiol. 1994;267:F331–F346
  20. Luiking YC, Weusten BLAM, Portincasa P, Van Der Meer R, Smout AJMP, Akkermans LMA. Effects of long term oral L-arginine on esophageal motility and gallbladder dynamics in healthy humans. Am J Phys. 1998;274:G984–G991
  21. Barbul A, Lazarou SA, Efron DT, Wasserkrug HL, Efron G. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery. 1990;108:331–337
  22. Clarkson P, Adams MR, Powe AJ, Donald AE, McCredle R, Robinson J, et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest. 1996;97:1989–1994
  23. Chin-Dusting JPF, Kaye DM, Lefkovits J, Wong J, Bergin P, Jennings GL. Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J Am Coll Cardiol. 1996;27:1207–1213
  24. Lerman A, Burnett JC, Higano St, McKinley LJ, Holmes DR. Long term L-arginine supplementation improves small vessel coronary endothelial function in humans. Circulation. 1998;97:2123–2128
  25. Herlitz H, Jungersten LU, Wikstrand J, Widgren BR. Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension. Kidney Int. 1999;56:1838–1845
  26. Beaumier L, Castillo L, Ajami AM, Young VR. Urea cycle intermediate kinetics and nitrate excretion at normal and “therapeutic” intakes of arginine in humans. Am J Physiol. 1995;269:E884–E896
  27. Theilmeier G, Chan JR, Zalpour C, Anderson B, Wang BY, Wolf A, et al. Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine. Arter Thromb Vasc Biol. 1997;17:3557–3564
  28. Baylis C, Vallance P. Measurement of nitrite and nitrate levels in plasma and urine—what does this measure tell us about the activity of the endogenous nitric oxide system?. Curr Opin Nephrol Hypertens. 1998;7:59–62
  29. Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, et al. Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998;98:1842–1847
  30. Bode-Boger SM, Boger RH, Kienke S, Junker W, Frölich JC. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Comm. 1996;219:598–603
  31. Anderstam B, Katzarski K, Bergström J. Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. J Am Soc Nephrol. 1997;8:1437–1442
  32. Fleck C, Janz A, Schweitzer F, Karge E, Schwertefeger M, Stein G. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int. 2001;59:S14–S18
  33. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric synthesis in chronic renal failure. Lancet. 1992;339:572–575
  34. Floyd JC, Fajans SS, Conn JW, Knopf RF, Rull J. Insulin secretion in response to protein ingestion. J Clin Invest. 1966;45:1479–1486
  35. Floyd JC, Fajans SS, Conn JLS, Knopf RF, Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest. 1966;45:1487–1502

PII: S0955-2863(04)00074-9

doi: 10.1016/j.jnutbio.2004.03.005

The Journal of Nutritional Biochemistry
Volume 15, Issue 9 , Pages 534-539 , September 2004

Article Tools